DEB-TACE: Clinical Trials

3 trials of DEB-TACE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 1, Terminated 1, Unknown 1

Follow DEB-TACE: new trials by email Literature Review of DEB-TACE trials Research Report on DEB-TACE

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DEB-TACE vs cTACE in HCC After TIPS
DEB-TACE, cTACE - Hepatocellular Carcinoma (HCC), TACE
Phase 3RecruitingFirst Affiliated Hospital, Sun Yat-Sen University2062025-12-012026-05-01
Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma
DEB-TACE, TAE - Carcinoma, Hepatocellular
Phase 3UnknownIRCCS Azienda Ospedaliero-Universitaria di Bologna1542019-12-042021-03-19
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
DEB-TACE, Sorafenib - Hepatocellular Carcinoma, Hepatoma
Phase 3TerminatedBoston Scientific Corporation22015-11-012021-02-12

Conditions studied

Carcinoma, Hepatocellular (3)

Sponsors

Boston Scientific Corporation (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)

Countries

China (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Anastasia Becker (1)  ·  Rita Golfieri, Professor (1)